{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T12:37:57Z","timestamp":1764074277750,"version":"3.45.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-025-01028-5","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T12:36:02Z","timestamp":1764074162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cepharanthine inhibits the proliferation and epithelial-mesenchymal transition of oral squamous cell carcinoma via HMGA2\/FOXL2 axis"],"prefix":"10.1186","volume":"26","author":[{"given":"Yuhua","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"issue":"Suppl 1","key":"1028_CR1","first-page":"S91","volume":"63","author":"T Wong","year":"2018","unstructured":"Wong T, Wiesenfeld D. Oral cancer. Aust Dent J. 2018;63(Suppl 1):S91\u20139.","journal-title":"AUST DENT J"},{"issue":"2","key":"1028_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/14737140.2019.1561288","volume":"19","author":"I Panarese","year":"2019","unstructured":"Panarese I, Aquino G, Ronchi A, Longo F, Montella M, Cozzolino I, Roccuzzo G, Colella G, Caraglia M, Franco R. Oral and oropharyngeal squamous cell carcinoma: prognostic and predictive parameters in the etiopathogenetic route. Expert Rev Anticanc. 2019;19(2):105\u201319.","journal-title":"EXPERT REV ANTICANC"},{"key":"1028_CR3","doi-asserted-by":"crossref","unstructured":"Mehra R, Seiwert TY, Mahipal A, Weiss J, Berger R, Eder JP, Burtness B, Tahara M, Keam B, Le DT et al. Efficacy and safety of pembrolizumab in recurrent\/metastatic head and neck squamous cell carcinoma (R\/M HNSCC): Pooled analyses after long-term follow-up in KEYNOTE-012. J Clin Oncol : 2016;34(15_suppl):6012.","DOI":"10.1200\/JCO.2016.34.15_suppl.6012"},{"issue":"5","key":"1028_CR4","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/jop.12643","volume":"47","author":"AM Alves","year":"2018","unstructured":"Alves AM, Diel LF, Lamers ML. Macrophages and prognosis of oral squamous cell carcinoma: A systematic review. J Oral Pathol Med. 2018;47(5):460\u20137.","journal-title":"J ORAL PATHOL MED"},{"key":"1028_CR5","doi-asserted-by":"crossref","unstructured":"Abnet CC, Arnold M, Wei WQ. Epidemiology of esophageal squamous cell carcinoma. Gastroenterology. 2018;154(2):360\u201373.","DOI":"10.1053\/j.gastro.2017.08.023"},{"issue":"3","key":"1028_CR6","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/ijc.32152","volume":"145","author":"I Ganly","year":"2019","unstructured":"Ganly I, Yang L, Giese RA, Hao Y, Nossa CW, Morris LGT, Rosenthal M, Migliacci J, Kelly D, Tseng W, et al. Periodontal pathogens are a risk factor of oral cavity squamous cell carcinoma, independent of tobacco and alcohol and human papillomavirus. Int J Cancer. 2019;145(3):775\u201384.","journal-title":"INT J CANCER"},{"issue":"13","key":"1028_CR7","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1101\/gad.262766.115","volume":"29","author":"Y Yue","year":"2015","unstructured":"Yue Y, Liu J, He C. RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation. Gene Dev. 2015;29(13):1343\u201355.","journal-title":"GENE DEV"},{"key":"1028_CR8","doi-asserted-by":"publisher","first-page":"108613","DOI":"10.1016\/j.biopha.2019.108613","volume":"112","author":"T Sun","year":"2019","unstructured":"Sun T, Wu R, Ming L. The role of m6A RNA methylation in cancer. Biomed Pharmacother. 2019;112:108613.","journal-title":"BIOMED PHARMACOTHER"},{"key":"1028_CR9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.yrtph.2018.09.010","volume":"99","author":"Q Zhou","year":"2018","unstructured":"Zhou Q, Xi S. A review on arsenic carcinogenesis: Epidemiology, metabolism, genotoxicity and epigenetic changes. REGUL TOXICOL PHARM. 2018;99:78\u201388.","journal-title":"REGUL TOXICOL PHARM"},{"issue":"3","key":"1028_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Bio. 2014;15(3):178\u201396.","journal-title":"NAT REV MOL CELL BIO"},{"issue":"7","key":"1028_CR11","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/1878-0261.12092","volume":"11","author":"MC Karlsson","year":"2017","unstructured":"Karlsson MC, Gonzalez SF, Welin J, Fuxe J. Epithelial-mesenchymal transition in cancer metastasis through the lymphatic system. Mol Oncol. 2017;11(7):781\u201391.","journal-title":"MOL ONCOL"},{"issue":"10","key":"1028_CR12","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.7150\/ijbs.35541","volume":"15","author":"Q Zhou","year":"2019","unstructured":"Zhou Q, Chen S, Lu M, Luo Y, Wang G, Xiao Y, Ju L, Wang X. EFEMP2 suppresses epithelial-mesenchymal transition via Wnt\/beta-catenin signaling pathway in human bladder cancer. Int J Biol Sci. 2019;15(10):2139\u201355.","journal-title":"INT J BIOL SCI"},{"issue":"3","key":"1028_CR13","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/dvdy.24485","volume":"247","author":"DL Gibbons","year":"2018","unstructured":"Gibbons DL, Creighton CJ. Pan-cancer survey of epithelial\u2013mesenchymal transition markers across the cancer genome atlas. Dev Dynam. 2018;247(3):555\u201364.","journal-title":"DEV DYNAM"},{"issue":"1","key":"1028_CR14","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3390\/ijms22010277","volume":"22","author":"J Kozak","year":"2020","unstructured":"Kozak J, Forma A, Czeczelewski M, Kozyra P, Sitarz E, Radzikowska-B\u00fcchner E, Sitarz M, Baj J. Inhibition or reversal of the Epithelial-Mesenchymal transition in gastric cancer: Pharmacological approaches. Int J Mol Sci. 2020;22(1):277.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1028_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/jb\/mvy047","volume":"164","author":"M Saitoh","year":"2018","unstructured":"Saitoh M. Involvement of partial EMT in cancer progression. J Biochem. 2018;164(4):257\u201364.","journal-title":"J BIOCHEM"},{"issue":"4","key":"1028_CR16","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/cjp2.142","volume":"5","author":"A Borretzen","year":"2019","unstructured":"Borretzen A, Gravdal K, Haukaas SA, Beisland C, Akslen LA, Halvorsen OJ. FOXC2 expression and epithelial-mesenchymal phenotypes are associated with castration resistance, metastasis and survival in prostate cancer. J Pathol Clin Res. 2019;5(4):272\u201386.","journal-title":"J PATHOL CLIN RES"},{"key":"1028_CR17","doi-asserted-by":"publisher","first-page":"721959","DOI":"10.3389\/fonc.2021.721959","volume":"11","author":"T Ray","year":"2021","unstructured":"Ray T, Ryusaki T, Ray PS. Therapeutically targeting cancers that overexpress FOXC1: A transcriptional driver of cell Plasticity, partial EMT, and cancer metastasis. Front Oncol. 2021;11:721959.","journal-title":"FRONT ONCOL"},{"issue":"1","key":"1028_CR18","doi-asserted-by":"publisher","first-page":"6548","DOI":"10.1038\/s41467-022-34239-z","volume":"13","author":"AV Mitchell","year":"2022","unstructured":"Mitchell AV, Wu L, James Block C, Zhang M, Hackett J, Craig DB, Chen W, Zhao Y, Zhang B, Dang Y, et al. FOXQ1 recruits the MLL complex to activate transcription of EMT and promote breast cancer metastasis. Nat Commun. 2022;13(1):6548.","journal-title":"NAT COMMUN"},{"issue":"6","key":"1028_CR19","doi-asserted-by":"publisher","first-page":"109827","DOI":"10.1016\/j.isci.2024.109827","volume":"27","author":"Q Li","year":"2024","unstructured":"Li Q, Wang T, Wang X, Ge X, Yang T, Wang W. DDX56 promotes EMT and cancer stemness via MELK-FOXM1 axis in hepatocellular carcinoma. Iscience. 2024;27(6):109827.","journal-title":"ISCIENCE"},{"issue":"13","key":"1028_CR20","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1158\/1078-0432.CCR-16-2180","volume":"23","author":"J Dong","year":"2017","unstructured":"Dong J, Wang R, Ren G, Li X, Wang J, Sun Y, Liang J, Nie Y, Wu K, Feng B, et al. HMGA2-FOXL2 axis regulates metastases and Epithelial-to-Mesenchymal transition of chemoresistant gastric cancer. Clin Cancer Res. 2017;23(13):3461\u201373.","journal-title":"CLIN CANCER RES"},{"key":"1028_CR21","doi-asserted-by":"publisher","first-page":"152956","DOI":"10.1016\/j.phymed.2019.152956","volume":"62","author":"C Bailly","year":"2019","unstructured":"Bailly C. Cepharanthine: an update of its mode of action, Pharmacological properties and medical applications. Phytomedicine (Stuttgart). 2019;62:152956.","journal-title":"Phytomedicine (Stuttgart)"},{"issue":"5","key":"1028_CR22","first-page":"647","volume":"19","author":"R Suzuki","year":"1992","unstructured":"Suzuki R, Hara M, Shindoh J, Matsumoto S, Noda Y, Gonda H, Tanaka H, Taki F, Takagi K. Effects of cepharanthin on leukopenia and thrombocytopenia induced by chemotherapy in lung cancer patients. Gan Kagaku Ryoho. 1992;19(5):647.","journal-title":"Gan Kagaku Ryoho"},{"issue":"6","key":"1028_CR23","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3892\/ol.2020.12191","volume":"20","author":"A Kiyomi","year":"2020","unstructured":"Kiyomi A, Miyakawa R, Matsumoto J, Yamazaki K, Imai S, Yuan B, Hirano T, Sugiura M. Potent antitumor activity of cepharanthine against triple\u2013negative breast cancer spheroids compared with tetrandrine. Oncol Lett. 2020;20(6):331.","journal-title":"ONCOL LETT"},{"issue":"1","key":"1028_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1055\/a-0706-7503","volume":"85","author":"V Payon","year":"2019","unstructured":"Payon V, Kongsaden C, Ketchart W, Mutirangura A, Wonganan P. Mechanism of cepharanthine cytotoxicity in human ovarian cancer cells. Planta Med. 2019;85(1):41\u20137.","journal-title":"PLANTA MED"},{"issue":"10","key":"1028_CR25","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.3390\/ijms20102473","volume":"20","author":"J Sakata","year":"2019","unstructured":"Sakata J, Hirosue A, Yoshida R, Kawahara K, Matsuoka Y, Yamamoto T, Nakamoto M, Hirayama M, Takahashi N, Nakamura T, et al. HMGA2 contributes to distant metastasis and poor prognosis by promoting angiogenesis in oral squamous cell carcinoma. Int J Mol Sci. 2019;20(10):2473.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1028_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13148-023-01506-9","volume":"15","author":"Z Yang","year":"2023","unstructured":"Yang Z, Liu F, Li Z, Liu N, Yao X, Zhou Y, Zhang L, Jiang P, Liu H, Kong L, et al. Histone lysine methyltransferase SMYD3 promotes oral squamous cell carcinoma tumorigenesis via H3K4me3-mediated HMGA2 transcription. Clin Epigenetics. 2023;15(1):92.","journal-title":"CLIN EPIGENETICS"},{"key":"1028_CR27","doi-asserted-by":"crossref","unstructured":"Wang Y, Chen Y, Liang J, Jiang M, Zhang T, Wan X, Wu J, Li X, Chen J, Sun J et al. METTL3-mediated m6A modification of HMGA2 mRNA promotes subretinal fibrosis and epithelial-mesenchymal transition. J Mol Cell Biol 2023, 15(3).","DOI":"10.1093\/jmcb\/mjad005"},{"issue":"1","key":"1028_CR28","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41420-023-01752-z","volume":"9","author":"Y Lu","year":"2023","unstructured":"Lu Y, Zhu C, Ding Y, Wang B, Zhao S, Lv J, Chen S, Wang S, Wang Y, Wang R, et al. Cepharanthine, a regulator of keap1-Nrf2, inhibits gastric cancer growth through oxidative stress and energy metabolism pathway. Cell Death Discov. 2023;9(1):450.","journal-title":"CELL DEATH DISCOV"},{"issue":"5","key":"1028_CR29","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.3892\/ol.2017.5945","volume":"13","author":"Q Zhu","year":"2017","unstructured":"Zhu Q, Guo B, Chen L, Ji Q, Liang H, Wen N, Zhang L. Cepharanthine exerts antitumor activity on choroidal melanoma by reactive oxygen species production and c-Jun N-terminal kinase activation. Oncol Lett. 2017;13(5):3760\u20136.","journal-title":"ONCOL LETT"},{"issue":"4","key":"1028_CR30","first-page":"1040","volume":"9","author":"M Sommariva","year":"2020","unstructured":"Sommariva M, Gagliano N. E-Cadherin in pancreatic ductal adenocarcinoma: A multifaceted actor during EMT. Cells (Basel Switzerland). 2020;9(4):1040.","journal-title":"Cells (Basel Switzerland)"},{"issue":"1","key":"1028_CR31","doi-asserted-by":"publisher","first-page":"5127","DOI":"10.1038\/s41467-020-18929-0","volume":"11","author":"H Tian","year":"2020","unstructured":"Tian H, Lian R, Li Y, Liu C, Liang S, Li W, Tao T, Wu X, Ye Y, Yang X, et al. AKT-induced LncRNA VAL promotes EMT-independent metastasis through diminishing Trim16-dependent vimentin degradation. Nat Commun. 2020;11(1):5127.","journal-title":"NAT COMMUN"},{"issue":"7","key":"1028_CR32","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/jso.23020","volume":"105","author":"H Kurahara","year":"2012","unstructured":"Kurahara H, Takao S, Maemura K, Mataki Y, Kuwahata T, Maeda K, Ding Q, Sakoda M, Iino S, Ishigami S, et al. Epithelial-mesenchymal transition and mesenchymal-epithelial transition via regulation of ZEB-1 and ZEB-2 expression in pancreatic cancer. J Surg Oncol. 2012;105(7):655\u201361.","journal-title":"J SURG ONCOL"},{"issue":"4","key":"1028_CR33","first-page":"775","volume":"55","author":"S Zhang","year":"2019","unstructured":"Zhang S, Mo Q, Wang X. Oncological role of HMGA2 (Review). Int J Oncol. 2019;55(4):775\u201388.","journal-title":"INT J ONCOL"},{"issue":"1","key":"1028_CR34","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3233\/CBM-170310","volume":"21","author":"L Yu","year":"2017","unstructured":"Yu L, Chen J, Liu Y, Zhang Z, Duan S. MicroRNA-937 inhibits cell proliferation and metastasis in gastric cancer cells by downregulating FOXL2. Cancer Biomark. 2017;21(1):105\u201316.","journal-title":"CANCER BIOMARK"},{"issue":"10","key":"1028_CR35","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","volume":"20","author":"S Zaccara","year":"2019","unstructured":"Zaccara S, Ries RJ, Jaffrey SR. Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell BIO. 2019;20(10):608\u201324.","journal-title":"NAT REV MOL CELL BIO"},{"issue":"11","key":"1028_CR36","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1016\/j.celrep.2017.02.059","volume":"18","author":"Q Cui","year":"2017","unstructured":"Cui Q, Shi H, Ye P, Li L, Qu Q, Sun G, Sun G, Lu Z, Huang Y, Yang C, et al. m6A RNA methylation regulates the Self-Renewal and tumorigenesis of glioblastoma stem cells. Cell Rep (Cambridge). 2017;18(11):2622\u201334.","journal-title":"Cell Rep (Cambridge)"},{"issue":"1","key":"1028_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-020-01249-8","volume":"19","author":"M Wang","year":"2020","unstructured":"Wang M, Liu J, Zhao Y, He R, Xu X, Guo X, Li X, Xu S, Miao J, Guo J, et al. Upregulation of METTL14 mediates the elevation of PERP mRNA N6 adenosine methylation promoting the growth and metastasis of pancreatic cancer. Mol Cancer. 2020;19(1):1\u2013130.","journal-title":"MOL CANCER"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-01028-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-025-01028-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-01028-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T12:36:05Z","timestamp":1764074165000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-025-01028-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1028"],"URL":"https:\/\/doi.org\/10.1186\/s40360-025-01028-5","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"8 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of MDKN Biotechnology Co., Lt. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors approved the final manuscript and the submission to this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"197"}}